Doctor profile · Federal record

Dr. MITCHELL AKMAN, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Specialist · REDDING, CA

  • NPI 1831266345
  • Accepts Medicare
  • 39 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1555 EAST ST, SUITE 300
REDDING, CA 960011153
(530) 229-1844
fax (530) 243-6397
Mailing address
PO BOX 6971
LINCOLN, NE 685060971

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
January 19, 2024
Year of graduation
1987 — 39 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
California #A54308

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1831266345. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,992
Distinct HCPCS
7
Medicare allowed
$310,989
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 1,300 658 $130
99213 Established patient office or other outpatient visit, 20-29 minutes 865 504 $91
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 259 95 $34
G0008 Administration of influenza virus vaccine 204 201 $31
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage 161 161 $75
99205 New patient office or other outpatient visit, 60-74 minutes 158 158 $222
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free 45 43 $33

In context: peer comparison

Among 2 peers in this city , average services per provider: 375. This provider delivers 8.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,208
Transactions
69
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 19 $271.22
Amgen Inc. 20 $236.71
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $202.25
Lilly USA, LLC 8 $185.79
Radius Health, Inc. 1 $49.54
ABBVIE INC. 2 $46.12
BETA BIONICS, INC. 3 $36.66
Tandem Diabetes Care, Inc. 2 $32.42
Kyowa Kirin, Inc. 1 $28.03
Insulet Corporation 1 $26.86
Abbott Laboratories 1 $26.24
Xeris Pharmaceuticals, Inc. 1 $22.63
Ascendis Pharma Inc 1 $22.50
Medtronic, Inc. 1 $20.91

By nature of payment

Food and Beverage
$1,208

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,325
Patients
1,231
Total drug cost
$1,715,988
Drug Type Claims Patients Total cost
Levoxyl (Levothyroxine Sodium) Brand 1,217 324 $36,637
Synthroid (Levothyroxine Sodium) Brand 711 179 $85,875
Ozempic (Semaglutide) Brand 400 107 $748,384
Atorvastatin Calcium Generic 333 110 $5,116
Rosuvastatin Calcium Generic 234 73 $7,020
Pioglitazone Hcl Generic 207 61 $5,464
Metformin Hcl Er (Metformin Hcl) Brand 204 64 $5,729
Jardiance (Empagliflozin) Brand 179 56 $247,663
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 146 46 $145,243
Calcitriol Generic 131 36 $7,636

Hospital affiliations

CMS Hospital Compare